vs
NexPoint Real Estate Finance, Inc.（NREF）与SUTRO BIOPHARMA, INC.（STRO）财务数据对比。点击上方公司名可切换其他公司
SUTRO BIOPHARMA, INC.的季度营收约是NexPoint Real Estate Finance, Inc.的1.0倍（$11.6M vs $11.1M），SUTRO BIOPHARMA, INC.同比增速更快（-21.4% vs -48.8%）
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业，主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案，运营并管理抵押贷款及其他地产相关投资组合，为利益相关方提供经风险调整的稳定回报。
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
NREF vs STRO — 直观对比
营收规模更大
STRO
是对方的1.0倍
$11.1M
营收增速更快
STRO
高出27.5%
-48.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.1M | $11.6M |
| 净利润 | $24.0M | — |
| 毛利率 | — | — |
| 营业利润率 | — | — |
| 净利率 | 216.6% | — |
| 营收同比 | -48.8% | -21.4% |
| 净利润同比 | 58.7% | 35.4% |
| 每股收益（稀释后） | $0.47 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NREFSTRO
| Q4 25 | $11.1M | $11.6M | ||
| Q3 25 | $12.5M | $9.7M | ||
| Q2 25 | $12.1M | $63.7M | ||
| Q1 25 | $11.5M | $17.4M | ||
| Q4 24 | $21.7M | $14.8M | ||
| Q3 24 | $12.5M | $8.5M | ||
| Q2 24 | $6.7M | $25.7M | ||
| Q1 24 | $-12.8M | $13.0M |
净利润NREFSTRO
| Q4 25 | $24.0M | — | ||
| Q3 25 | $50.9M | $-56.9M | ||
| Q2 25 | $22.3M | $-11.5M | ||
| Q1 25 | $26.0M | $-76.0M | ||
| Q4 24 | $15.2M | $-72.4M | ||
| Q3 24 | $23.3M | $-48.8M | ||
| Q2 24 | $12.1M | $-48.0M | ||
| Q1 24 | $-14.6M | $-58.2M |
营业利润率NREFSTRO
| Q4 25 | — | — | ||
| Q3 25 | — | -499.9% | ||
| Q2 25 | — | -5.2% | ||
| Q1 25 | — | -393.8% | ||
| Q4 24 | — | -440.7% | ||
| Q3 24 | — | -797.2% | ||
| Q2 24 | — | -189.4% | ||
| Q1 24 | — | -435.0% |
净利率NREFSTRO
| Q4 25 | 216.6% | — | ||
| Q3 25 | 407.0% | -586.6% | ||
| Q2 25 | 184.5% | -18.0% | ||
| Q1 25 | 225.6% | -436.6% | ||
| Q4 24 | 69.9% | -489.2% | ||
| Q3 24 | 186.4% | -572.6% | ||
| Q2 24 | 179.7% | -186.8% | ||
| Q1 24 | 114.3% | -447.5% |
每股收益（稀释后）NREFSTRO
| Q4 25 | $0.47 | — | ||
| Q3 25 | $1.14 | $-0.67 | ||
| Q2 25 | $0.54 | $-0.14 | ||
| Q1 25 | $0.70 | $-0.91 | ||
| Q4 24 | $0.71 | $-27.63 | ||
| Q3 24 | $0.74 | $-0.59 | ||
| Q2 24 | $0.40 | $-0.59 | ||
| Q1 24 | $-0.83 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.1M | $141.4M |
| 总债务越低越好 | $771.2M | — |
| 股东权益账面价值 | $388.0M | $-132.5M |
| 总资产 | $5.3B | $173.8M |
| 负债/权益比越低杠杆越低 | 1.99× | — |
8季度趋势，按日历期对齐
现金及短期投资NREFSTRO
| Q4 25 | $31.1M | $141.4M | ||
| Q3 25 | $17.9M | $167.6M | ||
| Q2 25 | $9.1M | $205.1M | ||
| Q1 25 | $19.2M | $249.0M | ||
| Q4 24 | $3.9M | $316.9M | ||
| Q3 24 | $34.7M | $388.3M | ||
| Q2 24 | $4.3M | $375.6M | ||
| Q1 24 | $13.5M | $267.6M |
总债务NREFSTRO
| Q4 25 | $771.2M | — | ||
| Q3 25 | $720.9M | — | ||
| Q2 25 | $815.6M | — | ||
| Q1 25 | $831.5M | — | ||
| Q4 24 | $799.3M | — | ||
| Q3 24 | $815.5M | — | ||
| Q2 24 | $861.0M | — | ||
| Q1 24 | $843.3M | — |
股东权益NREFSTRO
| Q4 25 | $388.0M | $-132.5M | ||
| Q3 25 | $375.4M | $-87.3M | ||
| Q2 25 | $348.2M | $-32.1M | ||
| Q1 25 | $343.7M | $-25.8M | ||
| Q4 24 | $336.5M | $44.6M | ||
| Q3 24 | $335.8M | $111.2M | ||
| Q2 24 | $327.5M | $152.2M | ||
| Q1 24 | $327.1M | $98.0M |
总资产NREFSTRO
| Q4 25 | $5.3B | $173.8M | ||
| Q3 25 | $5.3B | $209.7M | ||
| Q2 25 | $5.4B | $262.4M | ||
| Q1 25 | $5.4B | $321.4M | ||
| Q4 24 | $5.4B | $387.2M | ||
| Q3 24 | $5.7B | $451.8M | ||
| Q2 24 | $6.6B | $489.0M | ||
| Q1 24 | $7.1B | $403.4M |
负债/权益比NREFSTRO
| Q4 25 | 1.99× | — | ||
| Q3 25 | 1.92× | — | ||
| Q2 25 | 2.34× | — | ||
| Q1 25 | 2.42× | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 2.43× | — | ||
| Q2 24 | 2.63× | — | ||
| Q1 24 | 2.58× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.5M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | -0.19× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NREFSTRO
| Q4 25 | $-4.5M | $-177.2M | ||
| Q3 25 | $8.1M | $-38.2M | ||
| Q2 25 | $3.3M | $-44.7M | ||
| Q1 25 | $16.0M | $-67.9M | ||
| Q4 24 | $4.4M | $-71.7M | ||
| Q3 24 | $14.7M | $-64.5M | ||
| Q2 24 | $-7.5M | $9.5M | ||
| Q1 24 | $17.7M | $-64.7M |
现金转化率NREFSTRO
| Q4 25 | -0.19× | — | ||
| Q3 25 | 0.16× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 0.62× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.63× | — | ||
| Q2 24 | -0.62× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
